TRXB SCHEDULE 13D: SEC filing

Filed with the SEC on · accession 0001829126-26-011242

TRXB filed a SCHEDULE 13D (schedule 13d) with the SEC on Oct 16, 2026. SV Biotech Crossover Opportunities Fund LP and affiliated SV Health Investors entities filed a joint Schedule 13D regarding their position in TRex Bio, Inc. common stock. The stock moved -1.1% by the first close after the filing.

Summary of the filing

SV Biotech Crossover Opportunities Fund LP and affiliated SV Health Investors entities filed a joint Schedule 13D regarding their position in TRex Bio, Inc. common stock. The filing includes a Joint Filing Agreement and information about the investment committee members.

Key details

Subject companyTRex Bio, Inc.
FilerSV Biotech Crossover Opportunities Fund LP
General partner of filerSV BCO I GP LLP
Affiliated investment managerSV Health Investors
Affiliated investment managerSV Health Managers
Managing partner, sv health investorsMichael Ross, Ph.D.
Managing partner, sv health investorsNikola Trbovic, Ph.D.
Managing partner, sv health managersCatherine Bingham
Partner, sv health investorsJamil Beg
Member, sv bco i gp llpJames Costine

How TRXB stock reacted

Close before

$14.16

Oct 15, 2026

First close after

-1.06%

$14.01

5 trading days

+9.46%

$15.50

Since filing

-6.36%

$13.26

✦ Ask GOAX AI about this filing — what it means for TRXB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TRXB?

Click here

Frequently asked questions

What did TRXB file with the SEC on Oct 16, 2026?

TRXB filed a SCHEDULE 13D (SEC filing). SV Biotech Crossover Opportunities Fund LP and affiliated SV Health Investors entities filed a joint Schedule 13D regarding their position in TRex Bio, Inc. common stock. The filing includes a Joint Filing Agreement and information about the investment committee members.

How do I read a SCHEDULE 13D?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).

How did TRXB stock react to this filing?

TRXB closed at $14.16 before the filing and $14.01 on Oct 16, 2026 (-1.06%). Five trading days later: $15.50 (+9.46%).

Other TRXB SEC filings

Get alerts when TRXB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days